Dr Jay B Gooze, MD | |
21 Gonic Rd, Rochester, NH 03867-3926 | |
(603) 332-3302 | |
(603) 332-9608 |
Full Name | Dr Jay B Gooze |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 21 Gonic Rd, Rochester, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841293214 | NPI | - | NPPES |
AA608 | Other | NH | HARVARD PILGRIM HEALTH |
0104194Y0NH01 | Other | NH | ANTHEM BCBS |
81184194 | Medicaid | NH | |
1483709 | Other | NH | CIGNA |
449260001 | Other | MEDICARE DURABLE EQUIP |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 5784 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jay B Gooze, MD 21 Gonic Rd, Rochester, NH 03867-3926 Ph: (603) 332-3302 | Dr Jay B Gooze, MD 21 Gonic Rd, Rochester, NH 03867-3926 Ph: (603) 332-3302 |
News Archive
Merck & Company has agreed to pay more than $650 million to resolve allegations that the pharmaceutical manufacturer failed to pay proper rebates to Medicaid and other government health care programs and paid illegal remuneration to health care providers to induce them to prescribe the company's products, the Justice Department has announced.
An intensive program that taught low-income, poorly educated diabetics to better manage their disease resulted in significantly improved long-term blood sugar control, according to Johns Hopkins researchers who designed and implemented the program.
Researchers at New York University's Courant Institute of Mathematical Sciences have received the George Bell Prize, given to the world's fastest supercomputing application, for creating software that simulates blood flow. The award, which includes a cash prize of $10,000 and is given by the Association for Computing Machinery (ACM), is shared with researchers at Georgia Tech and Oak Ridge National Laboratory (ORNL).
According to an FDA advisory panel, studies show that an experimental vaccine to prevent shingles can cut the rate of infection by about half in people 60 and older and help curb related pain.
› Verified 9 days ago